Response To: Correspondence on “Associations of Baseline Use of Biologic or Targeted Synthetic Dmards with Covid-19 Severity in Rheumatoid Arthritis” by Sparks Et Al

AuthID
P-00Y-DXB
5
Author(s)
Wallace, ZS
·
Sparks, JA
·
Robinson, PC
·
Yazdany, J
Tipo de Documento
Article
Year published
2021
Publicado
in Annals of the Rheumatic Diseases, ISSN: 0003-4967
Páginas: annrheumdis-2021-220960
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0003-4967
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.